Evaluation of the efficacy and safety of stimulated conduction system pacing in adult patients with congenital heart disease.

Evaluation of the efficacy and safety of stimulated conduction system pacing in adult patients with congenital heart disease. - Conduction system pacing in adult congenital heart disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058063

Enrollment

Registered

2025-06-03

Start date

2025-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult congenital heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients aged 18 years and over with congenital heart disease who are attending or being admitted to the Department of Cardiology, Kyushu University Hospital. (2) Patients who are judged to be suitable for a pacemaker due to bradycardia and who will undergo transvenous lead implantation. (3) Patients who fully understand the study and give written consent.

Exclusion criteria

Exclusion criteria: (1) Patients with active infections. (2) Patients with metal allergies. (3) Patients who are pregnant or may become pregnant. (4) Other patients deemed ineligible for participation in the study by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Comparison of the amount of change in ventricular ejection fraction before and after implantation in conduction system pacing and conventional apical pacing.	—

Secondary

Measure	Time frame
Acute success of conduction system pacing Frequency of lead reinsertion Change in ventricular ejection fraction before and after conduction system pacing	—

Countries

Japan

Contacts

Public ContactTomomi Nagayama

Kyushu University Hospital Department of Cardiovascular Medicine

nagayama.tomomi.325@m.kyushu-u.ac.jp0926425360

Outcome results